OMOP Concept 1735323
hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML Injection [Ocrevus Zunovo]
StandardDrugRxNorm2693466Branded Drug
Maps from
1
Descendants
0
Valid from
2 Dec 2024
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Source codes that map to this concept
1 source code normalizes to hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML Injection [Ocrevus Zunovo] via the OMOP "Maps to" relationship.
| Vocabulary | Code | Name | Type |
|---|---|---|---|
| HCPCS | J2351 | Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq | Non-standard |
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(36)Roll up to these when you need a wider cohort.
- 1hyaluronidase / ocrelizumab Injectable Product
- 1hyaluronidase / ocrelizumab Injection
- 1hyaluronidase / ocrelizumab Injection [Ocrevus Zunovo]
- 1hyaluronidase-ocsq 1000 UNT/ML
- 1hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML [Ocrevus Zunovo]
- 1ocrelizumab-ocsq 40 MG/ML
- 1Ocrevus Zunovo Injectable Product
- 2hyaluronidase
- 2hyaluronidase
- 2Injectable Product
- 2ocrelizumab
- 2ocrelizumab; parenteral
- 2OCREVUS ZUNOVO - ocrelizumab and hyaluronidase injection, solution
- 3Anti-CD20 antibody
- 3Anti-CD38 antibody
- 3Anti-HER2 antibody
- 3Anti-PD-L1 antibody
- 3Enzymes
- 3Light-chain (AL) amyloidosis medication
- 3Monoclonal antibodies
- 3Neutral
- 4Antineoplastic monoclonal antibody
- 4Drugs by local effect
- 4Immunostimulatory monoclonal antibody
- 4IMMUNOSUPPRESSANTS
Get this concept via the API
Resolve hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML Injection [Ocrevus Zunovo] - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/1735323?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card